Teladoc (TDOC) Health announced that it has signed a definitive agreement to acquire Catapult Health, a leading provider of virtual preventive care services. The company plans to leverage Catapult Health’s innovative approach to patient-centric at-home diagnostic testing, as well as its high-touch engagement and clinical support model, to complement Teladoc Health’s industry-leading suite of integrated solutions. Teladoc Health has signed a definitive agreement to acquire Catapult Health in an all-cash transaction for $65 million, with up to $5 million in additional contingent earnout consideration. Catapult Health’s trailing twelve-month revenue was approximately $30 million as of the third quarter of 2024. The transaction is expected to close in the first quarter of 2025, subject to customary closing conditions.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Teladoc call volume above normal and directionally bullish
- Teladoc price target raised to $12 from $11 at RBC Capital
- Teladoc price target lowered to $10.50 from $11.50 at BofA
- Study shows online therapy boom mostly benefited priviledged groups, NYT says
- Lilly cuts FY24 outlook, United Rentals to acquire H&E: Morning Buzz